Beagle Bioproducts
Columbus · Founded 2012
About Beagle Bioproducts
Beagle Bioproducts, Inc. was founded in January 2012 with the intent to emerge as the most reliable domestic supplier of cyanobacterial toxins for research and for the monitoring and mitigation of harmful algal blooms (HABs). Our products will be available consistently and affordably, and we will develop a new line of lower-grade toxin products for research applications that don’t require high-purity (and high-cost) toxins. Upon establishing ourselves in the U.S. market, we intend to expand to global markets so that these products will be available to people studying and mitigating HABs worldwide.
Company Facts
- Founded: 2012
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $440.0K
- Funding stage: Seed
- Last round: Seed (Mar 2013)
- Website: beaglebioproducts.com
- Phone: 614.682.6588
Social Profiles
Canonical: https://fsome.com/organization/beagle-bioproducts-8290809 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.